Tecfidera: Clinical Trials

5 trials of Tecfidera, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated. 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Completed 3, Terminated 2

Follow Tecfidera: new trials by email Literature Review of Tecfidera trials Research Report on Tecfidera

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Compare GI Tolerability Following Oral Administration of Bafiertam™ or Tecfidera to Healthy Volunteers
Bafiertam, Tecfidera - Multiple Sclerosis
Phase 1CompletedBanner Life Sciences LLC2102019-07-072020-01-18
Comparative Bioavailability of BAFIERTAM™ (Monomethyl Fumarate) and Tecfidera® (Dimethyl Fumarate) in Healthy Subjects
monomethyl fumarate 190 mg, dimethyl fumarate 240 mg - Relapsing Remitting Multiple Sclerosis
Phase 1CompletedBanner Life Sciences LLC502017-01-062022-12-30
Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Dimethyl Fumarate (DMF), Placebo Oral Tablet - Systemic Sclerosis, Pulmonary; Hypertension
Phase 1TerminatedRobert Lafyatis62016-12-012022-03-17
Dimethylfumarate (DMF) in Relapsed/Refractory CLL/SLL
dimethyl fumarate - Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 1TerminatedMichael Choi22016-06-012019-09-19
BG00012 Regional Absorption Study
dimethyl fumarate - Healthy
Phase 1CompletedBiogen322013-08-012015-02-16

Conditions studied

Hypertension, Pulmonary (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Multiple Sclerosis (1)  ·  Multiple Sclerosis, Relapsing-Remitting (1)  ·  Neoplasms (1)  ·  Recurrence (1)  ·  Scleroderma, Diffuse (1)  ·  Scleroderma, Systemic (1)

Sponsors

Banner Life Sciences LLC (2)  ·  Biogen (1)  ·  Michael Choi (1)  ·  Robert Lafyatis (1)

Countries

United States (3)  ·  United Kingdom (1)

Top investigators

Franck Rousseau, MD (1)  ·  Kathleen Doisy, MD (1)  ·  Michael Choi, MD (1)  ·  Robert A Lafyatis, MD (1)

Results publications

PMID 33797063